Percutaneous radiofrequency for the treatment of small renal masses: Analysis of outcomes and complications after 10 years of experience

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

“…Furthermore, we showed that the choice of treatment affected the risk of disease recurrence. Patients treated with ablative therapy had a 5.7 time higher risk for recurrence as compared with those treated with RN, in line with previous studies [19] . Albeit most recurrences after ablative treatment were local in the treated kidney, the proportion of patients with distant recurrent disease was not statistically different from that of surgically treated patients.…”